カテゴリ： 世界, 医療/バイオ, Market Monitor Global

薬物送達用リポソームのグローバル市場展望 2023年-2029年：リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他

■ 英語タイトル：Liposomes for Drug Delivery Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY7689）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY7689
■ 発行日：2023年7月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：112
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥481,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥625,300見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥721,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[薬物送達用リポソームのグローバル市場展望 2023年-2029年：リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の薬物送達用リポソーム市場規模と予測を収録しています。・世界の薬物送達用リポソーム市場：売上、2018年-2023年、2024年-2029年
・世界の薬物送達用リポソーム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の薬物送達用リポソーム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リポソームビタミン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

薬物送達用リポソームのグローバル主要企業は、Lipoid Kosmetik、 Lucas Meyer Cosmetics、 Nippon Fine Chemical、 Enoc Solutions、 Nanovec、 Lipotec、 Croda、 H&A Pharmachem、 Lipomize、 ID bio、 BioSpectrum、 Derma Clinical、 Kewpie Corporation、 Nanohealth Biotech、 Creative Biostructure、 Phenbiox、 NOF CORPORATION、 KYOWA PHARMA CHEMICAL、 Nikko Chemicalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、薬物送達用リポソームのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の薬物送達用リポソーム市場：タイプ別、2018年-2023年、2024年-2029年
世界の薬物送達用リポソーム市場：タイプ別市場シェア、2022年
・リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他

世界の薬物送達用リポソーム市場：用途別、2018年-2023年、2024年-2029年
世界の薬物送達用リポソーム市場：用途別市場シェア、2022年
・親水性治療薬、疎水性治療薬

世界の薬物送達用リポソーム市場：地域・国別、2018年-2023年、2024年-2029年
世界の薬物送達用リポソーム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における薬物送達用リポソームのグローバル売上、2018年-2023年
・主要企業における薬物送達用リポソームのグローバル売上シェア、2022年
・主要企業における薬物送達用リポソームのグローバル販売量、2018年-2023年
・主要企業における薬物送達用リポソームのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Lipoid Kosmetik、 Lucas Meyer Cosmetics、 Nippon Fine Chemical、 Enoc Solutions、 Nanovec、 Lipotec、 Croda、 H&A Pharmachem、 Lipomize、 ID bio、 BioSpectrum、 Derma Clinical、 Kewpie Corporation、 Nanohealth Biotech、 Creative Biostructure、 Phenbiox、 NOF CORPORATION、 KYOWA PHARMA CHEMICAL、 Nikko Chemicals

*************************************************************

・調査・分析レポートの概要
薬物送達用リポソーム市場の定義
市場セグメント
世界の薬物送達用リポソーム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の薬物送達用リポソーム市場規模
世界の薬物送達用リポソーム市場規模：2022年 VS 2029年
世界の薬物送達用リポソーム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの薬物送達用リポソームの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の薬物送達用リポソーム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他
薬物送達用リポソームのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：親水性治療薬、疎水性治療薬
薬物送達用リポソームの用途別グローバル売上・予測

・地域別市場分析
地域別薬物送達用リポソーム市場規模 2022年と2029年
地域別薬物送達用リポソーム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Lipoid Kosmetik、 Lucas Meyer Cosmetics、 Nippon Fine Chemical、 Enoc Solutions、 Nanovec、 Lipotec、 Croda、 H&A Pharmachem、 Lipomize、 ID bio、 BioSpectrum、 Derma Clinical、 Kewpie Corporation、 Nanohealth Biotech、 Creative Biostructure、 Phenbiox、 NOF CORPORATION、 KYOWA PHARMA CHEMICAL、 Nikko Chemicals
...

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
This report aims to provide a comprehensive presentation of the global market for Liposomes for Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes for Drug Delivery. This report contains market size and forecasts of Liposomes for Drug Delivery in global, including the following market information:
Global Liposomes for Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Liposomes for Drug Delivery Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Liposomes for Drug Delivery companies in 2022 (%)
The global Liposomes for Drug Delivery market was valued at US$ 3431.8 million in 2022 and is projected to reach US$ 4211.1 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomes for Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomes for Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Liposomes for Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Liposome Vitamin
Liposome Ceramide
Liposome CoQ10
Others
Global Liposomes for Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Liposomes for Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Hydrophilic Drugs
Hydrophobic Drugs
Global Liposomes for Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Liposomes for Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomes for Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Liposomes for Drug Delivery revenues share in global market, 2022 (%)
Key companies Liposomes for Drug Delivery sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Liposomes for Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liposomes for Drug Delivery, market overview.
Chapter 2: Global Liposomes for Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Liposomes for Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liposomes for Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Liposomes for Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Liposomes for Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomes for Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomes for Drug Delivery Overall Market Size
2.1 Global Liposomes for Drug Delivery Market Size: 2022 VS 2029
2.2 Global Liposomes for Drug Delivery Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Liposomes for Drug Delivery Sales: 2018-2029
3 Company Landscape
3.1 Top Liposomes for Drug Delivery Players in Global Market
3.2 Top Global Liposomes for Drug Delivery Companies Ranked by Revenue
3.3 Global Liposomes for Drug Delivery Revenue by Companies
3.4 Global Liposomes for Drug Delivery Sales by Companies
3.5 Global Liposomes for Drug Delivery Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Liposomes for Drug Delivery Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Liposomes for Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposomes for Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Liposomes for Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Liposomes for Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Liposomes for Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Liposome Vitamin
4.1.3 Liposome Ceramide
4.1.4 Liposome CoQ10
4.1.5 Others
4.2 By Type – Global Liposomes for Drug Delivery Revenue & Forecasts
4.2.1 By Type – Global Liposomes for Drug Delivery Revenue, 2018-2023
4.2.2 By Type – Global Liposomes for Drug Delivery Revenue, 2024-2029
4.2.3 By Type – Global Liposomes for Drug Delivery Revenue Market Share, 2018-2029
4.3 By Type – Global Liposomes for Drug Delivery Sales & Forecasts
4.3.1 By Type – Global Liposomes for Drug Delivery Sales, 2018-2023
4.3.2 By Type – Global Liposomes for Drug Delivery Sales, 2024-2029
4.3.3 By Type – Global Liposomes for Drug Delivery Sales Market Share, 2018-2029
4.4 By Type – Global Liposomes for Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Liposomes for Drug Delivery Market Size, 2022 & 2029
5.1.2 Hydrophilic Drugs
5.1.3 Hydrophobic Drugs
5.2 By Application – Global Liposomes for Drug Delivery Revenue & Forecasts
5.2.1 By Application – Global Liposomes for Drug Delivery Revenue, 2018-2023
5.2.2 By Application – Global Liposomes for Drug Delivery Revenue, 2024-2029
5.2.3 By Application – Global Liposomes for Drug Delivery Revenue Market Share, 2018-2029
5.3 By Application – Global Liposomes for Drug Delivery Sales & Forecasts
5.3.1 By Application – Global Liposomes for Drug Delivery Sales, 2018-2023
5.3.2 By Application – Global Liposomes for Drug Delivery Sales, 2024-2029
5.3.3 By Application – Global Liposomes for Drug Delivery Sales Market Share, 2018-2029
5.4 By Application – Global Liposomes for Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Liposomes for Drug Delivery Market Size, 2022 & 2029
6.2 By Region – Global Liposomes for Drug Delivery Revenue & Forecasts
6.2.1 By Region – Global Liposomes for Drug Delivery Revenue, 2018-2023
6.2.2 By Region – Global Liposomes for Drug Delivery Revenue, 2024-2029
6.2.3 By Region – Global Liposomes for Drug Delivery Revenue Market Share, 2018-2029
6.3 By Region – Global Liposomes for Drug Delivery Sales & Forecasts
6.3.1 By Region – Global Liposomes for Drug Delivery Sales, 2018-2023
6.3.2 By Region – Global Liposomes for Drug Delivery Sales, 2024-2029
6.3.3 By Region – Global Liposomes for Drug Delivery Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Liposomes for Drug Delivery Revenue, 2018-2029
6.4.2 By Country – North America Liposomes for Drug Delivery Sales, 2018-2029
6.4.3 US Liposomes for Drug Delivery Market Size, 2018-2029
6.4.4 Canada Liposomes for Drug Delivery Market Size, 2018-2029
6.4.5 Mexico Liposomes for Drug Delivery Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Liposomes for Drug Delivery Revenue, 2018-2029
6.5.2 By Country – Europe Liposomes for Drug Delivery Sales, 2018-2029
6.5.3 Germany Liposomes for Drug Delivery Market Size, 2018-2029
6.5.4 France Liposomes for Drug Delivery Market Size, 2018-2029
6.5.5 U.K. Liposomes for Drug Delivery Market Size, 2018-2029
6.5.6 Italy Liposomes for Drug Delivery Market Size, 2018-2029
6.5.7 Russia Liposomes for Drug Delivery Market Size, 2018-2029
6.5.8 Nordic Countries Liposomes for Drug Delivery Market Size, 2018-2029
6.5.9 Benelux Liposomes for Drug Delivery Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Liposomes for Drug Delivery Revenue, 2018-2029
6.6.2 By Region – Asia Liposomes for Drug Delivery Sales, 2018-2029
6.6.3 China Liposomes for Drug Delivery Market Size, 2018-2029
6.6.4 Japan Liposomes for Drug Delivery Market Size, 2018-2029
6.6.5 South Korea Liposomes for Drug Delivery Market Size, 2018-2029
6.6.6 Southeast Asia Liposomes for Drug Delivery Market Size, 2018-2029
6.6.7 India Liposomes for Drug Delivery Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Liposomes for Drug Delivery Revenue, 2018-2029
6.7.2 By Country – South America Liposomes for Drug Delivery Sales, 2018-2029
6.7.3 Brazil Liposomes for Drug Delivery Market Size, 2018-2029
6.7.4 Argentina Liposomes for Drug Delivery Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Liposomes for Drug Delivery Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Liposomes for Drug Delivery Sales, 2018-2029
6.8.3 Turkey Liposomes for Drug Delivery Market Size, 2018-2029
6.8.4 Israel Liposomes for Drug Delivery Market Size, 2018-2029
6.8.5 Saudi Arabia Liposomes for Drug Delivery Market Size, 2018-2029
6.8.6 UAE Liposomes for Drug Delivery Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Lipoid Kosmetik
7.1.1 Lipoid Kosmetik Company Summary
7.1.2 Lipoid Kosmetik Business Overview
7.1.3 Lipoid Kosmetik Liposomes for Drug Delivery Major Product Offerings
7.1.4 Lipoid Kosmetik Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.1.5 Lipoid Kosmetik Key News & Latest Developments
7.2 Lucas Meyer Cosmetics
7.2.1 Lucas Meyer Cosmetics Company Summary
7.2.2 Lucas Meyer Cosmetics Business Overview
7.2.3 Lucas Meyer Cosmetics Liposomes for Drug Delivery Major Product Offerings
7.2.4 Lucas Meyer Cosmetics Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.2.5 Lucas Meyer Cosmetics Key News & Latest Developments
7.3 Nippon Fine Chemical
7.3.1 Nippon Fine Chemical Company Summary
7.3.2 Nippon Fine Chemical Business Overview
7.3.3 Nippon Fine Chemical Liposomes for Drug Delivery Major Product Offerings
7.3.4 Nippon Fine Chemical Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.3.5 Nippon Fine Chemical Key News & Latest Developments
7.4 Enoc Solutions
7.4.1 Enoc Solutions Company Summary
7.4.2 Enoc Solutions Business Overview
7.4.3 Enoc Solutions Liposomes for Drug Delivery Major Product Offerings
7.4.4 Enoc Solutions Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.4.5 Enoc Solutions Key News & Latest Developments
7.5 Nanovec
7.5.1 Nanovec Company Summary
7.5.2 Nanovec Business Overview
7.5.3 Nanovec Liposomes for Drug Delivery Major Product Offerings
7.5.4 Nanovec Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.5.5 Nanovec Key News & Latest Developments
7.6 Lipotec
7.6.1 Lipotec Company Summary
7.6.2 Lipotec Business Overview
7.6.3 Lipotec Liposomes for Drug Delivery Major Product Offerings
7.6.4 Lipotec Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.6.5 Lipotec Key News & Latest Developments
7.7 Croda
7.7.1 Croda Company Summary
7.7.2 Croda Business Overview
7.7.3 Croda Liposomes for Drug Delivery Major Product Offerings
7.7.4 Croda Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.7.5 Croda Key News & Latest Developments
7.8 H&A Pharmachem
7.8.1 H&A Pharmachem Company Summary
7.8.2 H&A Pharmachem Business Overview
7.8.3 H&A Pharmachem Liposomes for Drug Delivery Major Product Offerings
7.8.4 H&A Pharmachem Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.8.5 H&A Pharmachem Key News & Latest Developments
7.9 Lipomize
7.9.1 Lipomize Company Summary
7.9.2 Lipomize Business Overview
7.9.3 Lipomize Liposomes for Drug Delivery Major Product Offerings
7.9.4 Lipomize Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.9.5 Lipomize Key News & Latest Developments
7.10 ID bio
7.10.1 ID bio Company Summary
7.10.2 ID bio Business Overview
7.10.3 ID bio Liposomes for Drug Delivery Major Product Offerings
7.10.4 ID bio Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.10.5 ID bio Key News & Latest Developments
7.11 BioSpectrum
7.11.1 BioSpectrum Company Summary
7.11.2 BioSpectrum Liposomes for Drug Delivery Business Overview
7.11.3 BioSpectrum Liposomes for Drug Delivery Major Product Offerings
7.11.4 BioSpectrum Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.11.5 BioSpectrum Key News & Latest Developments
7.12 Derma Clinical
7.12.1 Derma Clinical Company Summary
7.12.2 Derma Clinical Liposomes for Drug Delivery Business Overview
7.12.3 Derma Clinical Liposomes for Drug Delivery Major Product Offerings
7.12.4 Derma Clinical Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.12.5 Derma Clinical Key News & Latest Developments
7.13 Kewpie Corporation
7.13.1 Kewpie Corporation Company Summary
7.13.2 Kewpie Corporation Liposomes for Drug Delivery Business Overview
7.13.3 Kewpie Corporation Liposomes for Drug Delivery Major Product Offerings
7.13.4 Kewpie Corporation Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.13.5 Kewpie Corporation Key News & Latest Developments
7.14 Nanohealth Biotech
7.14.1 Nanohealth Biotech Company Summary
7.14.2 Nanohealth Biotech Business Overview
7.14.3 Nanohealth Biotech Liposomes for Drug Delivery Major Product Offerings
7.14.4 Nanohealth Biotech Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.14.5 Nanohealth Biotech Key News & Latest Developments
7.15 Creative Biostructure
7.15.1 Creative Biostructure Company Summary
7.15.2 Creative Biostructure Business Overview
7.15.3 Creative Biostructure Liposomes for Drug Delivery Major Product Offerings
7.15.4 Creative Biostructure Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.15.5 Creative Biostructure Key News & Latest Developments
7.16 Phenbiox
7.16.1 Phenbiox Company Summary
7.16.2 Phenbiox Business Overview
7.16.3 Phenbiox Liposomes for Drug Delivery Major Product Offerings
7.16.4 Phenbiox Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.16.5 Phenbiox Key News & Latest Developments
7.17 NOF CORPORATION
7.17.1 NOF CORPORATION Company Summary
7.17.2 NOF CORPORATION Business Overview
7.17.3 NOF CORPORATION Liposomes for Drug Delivery Major Product Offerings
7.17.4 NOF CORPORATION Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.17.5 NOF CORPORATION Key News & Latest Developments
7.18 KYOWA PHARMA CHEMICAL
7.18.1 KYOWA PHARMA CHEMICAL Company Summary
7.18.2 KYOWA PHARMA CHEMICAL Business Overview
7.18.3 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Major Product Offerings
7.18.4 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.18.5 KYOWA PHARMA CHEMICAL Key News & Latest Developments
7.19 Nikko Chemicals
7.19.1 Nikko Chemicals Company Summary
7.19.2 Nikko Chemicals Business Overview
7.19.3 Nikko Chemicals Liposomes for Drug Delivery Major Product Offerings
7.19.4 Nikko Chemicals Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.19.5 Nikko Chemicals Key News & Latest Developments
8 Global Liposomes for Drug Delivery Production Capacity, Analysis
8.1 Global Liposomes for Drug Delivery Production Capacity, 2018-2029
8.2 Liposomes for Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposomes for Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Liposomes for Drug Delivery Supply Chain Analysis
10.1 Liposomes for Drug Delivery Industry Value Chain
10.2 Liposomes for Drug Delivery Upstream Market
10.3 Liposomes for Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liposomes for Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ナノテクノロジードラッグデリバリーシステムのグローバル市場展望 2023年-2029年：リポソーム医薬品、脂質ナノ粒子医薬品
  • 注射用薬物送達システムのグローバル市場展望 2023年-2029年：充填済み注射器、自動注射器（シリンジ式およびカートリッジ式）、ペン型注射器、その他
  • マイクロニードル媒介薬物送達パッチのグローバル市場展望 2023年-2029年：中空マイクロニードル技術、中実マイクロニードル技術、溶解マイクロニードル技術
  • 遺伝子治療薬送達チューブのグローバル市場展望 2023年-2029年：延長チューブタイプ、静脈カテーテルタイプ
  • 眼科用徐放性ドラッグデリバリーシステムのグローバル市場展望 2023年-2029年：リポソーム、マイクロカプセル/ナノカプセル、マイクロスフィア/ナノスフィア、インプラント
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY7689 )"薬物送達用リポソームのグローバル市場展望 2023年-2029年：リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他" (英文：Liposomes for Drug Delivery Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。